Adult medulloblastoma: Multiagent chemotherapy with cisplatinum and etoposide: A single institutional experience

Journal of Neuro-Oncology

Volumn 106, Issue 3, 2012, Pages 595-600

  Silvani, A ^a   Gaviani, P ^a   Lamperti, E ^a   Botturi, A ^a   DiMeco, F ^a,b   Franzini, A ^a   Ferroli, P ^a   Fariselli, L ^a   Milanesi, I ^a   Erbetta, A ^a   Pollo, B ^a   Salmaggi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adult patients; Chemotherapy; Cisplatinum; Etoposide; Medulloblastoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTARABINE; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADULT; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CREATININE CLEARANCE; CYBERKNIFE; DRUG MEGADOSE; FEMALE; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MEDULLOBLASTOMA; MENINGEAL METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERCEPTION DEAFNESS; POSTERIOR CRANIAL FOSSA TUMOR; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; SENSORY NEUROPATHY; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84857049683     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0696-0     Document Type: Article

References (26)

1. Giordana MT, Schiffer P, Lanotte M, Girardi P, Chio A (1999) Epidemiology of adult medulloblastoma. Int J Cancer 80: 689-692 (Pubitemid 29066279)
2. Giordana MT, Cavalla P, Dutto A, Borsotti L, Chio A, Schiffer D (1997) Is medulloblastoma the same tumor in children and adults? J Neurooncol 35: 169-176 (Pubitemid 27361687)
3. Louis DN, Ohgaki H, Wiestler OD, Caveny WK (2007) WHO Classification of tumours of the central nervous system. IARC Press, Lyon
4. Packer RJ, Rood BR, MacDonald TJ (2003) Medulloblastoma: present concepts of stratification into risk groups. Pediatr eurosurg 39: 60-67 (Pubitemid 36829097)
5. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a mega voltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93: 1351-1359
6. Common Toxicity Criteria (1998) Version 2.0DCTD, NCI, NIH, DHHS
7. Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M (2007) Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110: 2035-2341
8. Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH (1997) Adult medulloblastoma: an analysis of survival, prognostic factors. Cancer J Sci Am 3: 238-245
9. Bloom HJ, Bessell EM (1990) Medulloblastomain adults: a review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 18: 763-772 (Pubitemid 20154031)
10. Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie- Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, Lagrange JL, Maire JP, Cowen D, Frappaz D, Carrie C (2007) Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68: 433-440 (Pubitemid 46694158)
11. Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T (2009) Survival prognostic factors in a series of adults with medulloblastomas. J Neurosurg 111: 478-487
12. Kunschner LJ, Kuttesch J, Hess K, Yung WK (2001) Survival recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol 3: 167-173 (Pubitemid 33674108)
13. Mastrangelo S, Tornesello A, Mastrangelo R (1999) Chemotherapy of medulloblastoma. Med Pediatr Oncol 33: 116-119 (Pubitemid 29340021)
14. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment and residual treatment are prognostic factors for medulloblastomas in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17: 832-845 (Pubitemid 29109313)
15. Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A, Neidhardt MK (1995) Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Pediatric Oncology (SIOP) and the (German) Society of Pediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25: 166-178
16. Marks LB, Cuthbertson D, Friedman HS (1995) Hematological toxicity during craniospinal irradiation: the impact of prior chemotherapy. Med Pediatr Oncol 25: 45-51
17. Abd-El-Aal HH (2006) Pre-irradiation chemotherapy in high risk medulloblastoma. J Egypt Natl Canc Inst 18: 357-362
18. Boiardi A, Silvani A, Eoli M, Fariselli L, Zappacosta B, Salmaggi A (2000) Embryonal tumors in the adult population: implications in therapeutic planning. Neurol Sci 21: 23-30 (Pubitemid 30430855)
19. Yuki K, Uozumi T, Kodama Y, Kurisu K, Mikami T (1994) In vitro chemosensitivity test of human brain tumors using a three-dimensional organ culture with a collagen gel matrix. J Neurooncol 21: 225-232 (Pubitemid 24381471)
20. Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL (1990) Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol 8: 330-336 (Pubitemid 20056566)
21. Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U (2005) Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 12: 1184-1188
22. Liu AK, Marcus KJ, Fischl B, Grant PE, Young Poussaint T, Rivkin MJ, Davis P, Tarbell NJ, Yock TI (2007) Changes in cerebral cortex of children treated for medulloblastoma. Int J Radiat Oncol Biol Phys 68: 992-998 (Pubitemid 47048564)
23. Mazloom A, Zangeneh AH, Paulino AC (2010) Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys 78: 72-78
24. Paulino AC, Lobo M, Teh BS, Okcu MF, South M, Butler EB, Su J, Chintagumpala M (2010) Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys 78: 1445-1450
25. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, Reaman G, Cohen BH, Bruce DA, Rorke LB, Molloy P, Ryan J, LaFond D, Evans AE, Schut L (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81: 690-698 (Pubitemid 24328694)
26. Greenberg HS, Chamberlain MC, Glantz MJ, Wang S (2001) Adult medulloblastoma: multiagent chemotherapy. Neuro Oncol 3: 29-34 (Pubitemid 33685583)